← Back to Search

Unknown

TDM-105795 for Male Pattern Baldness

Phase 1
Waitlist Available
Research Sponsored by Technoderma Medicines Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 42 days
Awards & highlights

Study Summary

This trial is testing a new drug for male pattern baldness. The drug will be compared to a placebo to see if it is effective.

Eligible Conditions
  • Male Pattern Baldness

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~42 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 42 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Incidence rate of any local and systemic AEs
Number of participants with abnormal ECG readings
Number of participants with abnormal echocardiogram results
+3 more
Secondary outcome measures
Plasma concentrations of TDM-105795

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: MAD Cohorts 1-4 TDM-105795 topical solutionExperimental Treatment1 Intervention
Multiple dose administration of TDM-105795 Topical Solution, 0.0025% or 0.005% or 0.01% or 0.02%
Group II: Placebo for TDM-105795 topical solutionPlacebo Group1 Intervention
Multiple dose administration of Placebo forTDM-105795 Topical Solution
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
TDM-105795
2021
Completed Phase 1
~70

Find a Location

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Who is running the clinical trial?

Technoderma Medicines Inc.Lead Sponsor
4 Previous Clinical Trials
183 Total Patients Enrolled
Therapeutics, Inc.Industry Sponsor
30 Previous Clinical Trials
3,880 Total Patients Enrolled
Daniel Piacquadio, M.D.Study DirectorTherapeutics Incorporated
2 Previous Clinical Trials
440 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who else is applying?

What site did they apply to?
TCR Medical Corporation
J&S Studies, Inc.
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria
What state do they live in?
Texas
How many prior treatments have patients received?
0

Why did patients apply to this trial?

I found the trial on Clinicaltrials.gov. Non responder to 5ar inhibitors willing to try something new.
PatientReceived 1 prior treatment
Recent research and studies
clinicaltrials.govStudy
A Study of TDM-105795 in Male Subjects With Androgenetic Alopecia (AGA)
2022. "A Study of TDM-105795 in Male Subjects With Androgenetic Alopecia (AGA)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05244980.
~10 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top